Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

June 18, 2021

Study Completion Date

June 18, 2021

Conditions

Migraine

Interventions

DRUG

Atogepant

Oral; Tablet

DRUG

Ubrogepant

Oral; Tablet

Trial Locations (3)

Spaulding Clinical Research LLC /ID# 229505, West Bend

PPD Clinical Research Unit /ID# 227676, Orlando

Bio-Kinetic Clinical Applications, LLC /ID# 227675, Springfield